High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study

J Transl Med. 2010 Nov 10:8:115. doi: 10.1186/1479-5876-8-115.

Authors

Michele Guida¹, Antonio Cramarossa, Ettore Fistola, Mariangela Porcelli, Giuseppe Giudice, Katia Lubello, Giuseppe Colucci

Affiliation

¹ Department of Medical Oncology; National Institute of Cancer, Bari, Italy. micguida@libero.it

No abstract available

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Dacarbazine / administration & dosage
Dacarbazine / analogs & derivatives
Dose-Response Relationship, Drug
Feasibility Studies
Female
Humans
Male
Melanoma / drug therapy*
Melanoma / pathology
Middle Aged
Neoplasm Metastasis
Nitrosourea Compounds / administration & dosage
Organophosphorus Compounds / administration & dosage
Temozolomide

Substances

Nitrosourea Compounds
Organophosphorus Compounds
Dacarbazine
fotemustine
Temozolomide